Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression

Journal of the American College of Cardiology

Volumn 44, Issue 8, 2004, Pages 1609-1618

  Polyakova, Victoria ^a,c   Hein, Stefan ^b   Kostin, Sawa ^a   Ziegelhoeffer, Tibor ^a   Schaper, Jutta ^a  

^a MAX PLANCK INSTITUTE   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

^c MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ADULT; AGED; AORTA VALVE REPLACEMENT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE COURSE; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE PRESSURE; HUMAN; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; TURNOVER TIME; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

AGED; AORTIC VALVE STENOSIS; BIOPSY; CELL DIVISION; DISEASE PROGRESSION; ENDOCARDIUM; ENDOMYOCARDIAL FIBROSIS; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; HEART FAILURE, CONGESTIVE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MATRIX METALLOPROTEINASES; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MYOCARDIUM; PROTEIN ISOFORMS; REFERENCE VALUES; TISSUE INHIBITOR OF METALLOPROTEINASES; VENTRICULAR REMODELING;

EID: 5644304359     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.07.023     Document Type: Article

References (26)

1. S. Hein, E. Arnon, S Kostin Progression from compensated hypertrophy to failure in the pressure-overloaded human heart Structural deterioration and compensatory mechanisms Circulation 107 2003 984 991
2. Y. Nagamoto, B.A. Carabello, M.L Coker Differential effects of pressure or volume overload on myocardial MMP level and inhibitory control Am J Physiol Heart Circ Physiol 278 2000 H151 61
3. Y.Y. Li, A.M. Feldman, Y. Sun, C.F. McTiernan Differential expression of tissue inhibitors of metalloproteinases in the failing human heart Circulation 98 1998 1728 1734
4. D. Reinhardt, H.H. Sigusch, J. Hensse, S.C. Tyagi, R. Korfer, H.R. Figulla Cardiac remodeling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP Heart 88 2002 525 530
5. Y. Iwanaga, T. Aoyama, Y. Kihara, Y. Onozawa, T. Yoneda, S. Sasayama Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats J Am Coll Cardiol 39 2002 1384 1391
6. F.G. Spinale, M.L. Coker, C.V. Thomas, J.D. Walker, R. Mukherjee, L. Hebbar Time-dependent changes in matrix metalloproteinase activity and expression during progression of congestive heart failure Circulation 82 1998 482 495
7. J.T. Peterson, H. Li, L. Dilon, J.W. Bryant Evolution of matrix metalloproteinase and tissue inhibitor expression during heart failure progression in the infracted rat Cardiovasc Res 46 2000 307 315
8. T. Walther, A. Schubert, V Falk Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression Circulation 104 2001 I54 8
9. K.L. Faia, W.P. Davis, A.J. Marone, T.L. Foxall Matrix metalloproteinases and tissue inhibitors of metalloproteinases in hamster aortic atherosclerosis: correlation with in-situ zymography Atherosclerosis 160 2002 325 337
10. F.G. Spinale, M.L. Coker, L.J Heung A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure Circulation 102 2000 1944 1949
11. M.L. Coker, J.L. Zellner, A.J. Crumbley, F.G. Spinale Defects in matrix metalloproteinase inhibitory stochiometry and selective MMP induction in patients with nonischemic or ischemic dilated cardiomyopathy Ann N Y Acad Sci 878 1999 559 562
12. Y. Hojo, U. Ikeda, S. Ueno, H. Arakawa, K. Shimada Expression of matrix metalloproteinases in patients with acute myocardial infarction Jpn Circ J 65 2001 71 75
13. M. Pauschniger, K. Chandrasekharan, J. Li, P.L. Schwimmbeck, M. Noutsias, H.P. Schultheiss Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy Herz 27 2002 677 682
14. A.A. Gonzalez, A.M. Segura, K Horiba Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study Hum Pathol 33 2002 1158 1164
15. W.Q. Zhao, H. Li, K Yamashita Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP1) in the nuclei of human gingival fibroblasts J Cell Sci 111 1998 1147 1153
16. C. Boixel, V. Fontaine, C Rücke-Martin Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat J Am Coll Cardiol 42 2003 336 344
17. K.E. Dawes, A.D. Cambrey, J.S Campa Changes in collagen metabolism in response to endothelin-1 evidence for fibroblast heterogeneity Int J Biochem Cell Biol 28 1996 229 238
18. H.E. Van Beurden, P.A.M. Snoek, J.W. Von den Hoff, R. Torensma, A.M. Kuijpers-Jagtman Fibroblast subpopulation in intra-oral healing Wound Rep Reg 11 2003 55 63
19. I. Manabe, T. Shindo, R. Nagai Gene expression in fibroblasts and fibrosis Involvement in cardiac hypertrophy Circ Res 91 2002 1103 1113
20. H. Will, S.J. Atkinson, G.S. Butler, B. Smith, G. Murphy The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiate autoproteolytic activation: regulation by TIMP2 and TIMP 3 J Biol Chem 271 1996 17119 17123
21. E.J.M. Creemers, J.P.M. Cleutjens, J.F.M. Smits, M.J. Daemen Matrix metalloproteinase inhibition after myocardial infarction A new approach to prevent heart failure? Circ Res 89 2001 201 210
22. D.C. von Bredow, A.E. Cress, E.W. Howard, G.T. Bowden, R.B. Nagle Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complex by matrilysin Biochem J 331 1998 965 972
23. J. Greene, M. Wang, Y.E. Liu, L.A. Raymond, C. Rosen, Y.E. Shi Molecular cloning and characterization of human tissue inhibitors of metalloproteinase 4 J Biol Chem 271 1996 30375 30380
24. V.S. Mujumdar, S.C. Tyagi Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure J Hypertens 17 1999 261 270
25. H. Li, H. Simon, T.M.A. Bocan, J.T. Peterson MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition Cardiovasc Res 46 2000 298 306
26. Y.Y. Li, T. Kadokami, P. Wang, C.F. McTierman, A.M. Feldman MMP inhibition modulates TNF-α transgenic mouse phenotype early in the development of heart failure Am J Physiol Heart Circ Physiol 282 2002 H983 9